New Multi-Organ Protein Clocks Predict Disease and Mortality Better Than Single-Organ Measures
Researchers built 11 proteome-based biological age clocks from 2,448 plasma proteins across 43,000+ participants, revealing how organ-spanning data improves longevity predictions.
Summary
Scientists developed 11 new biological age clocks using nearly 2,500 plasma proteins measured in over 43,000 UK Biobank participants. Each clock targets a different organ system, using protein levels in the blood as a molecular window into how fast that organ is aging. When these protein-based clocks were combined with previously developed clocks built from clinical measurements and imaging, the integrated multi-organ approach predicted systemic diseases and all-cause mortality more accurately than any single-organ measure alone. The study also uncovered genetic overlaps and causal links between biological age gaps and specific disease outcomes. Crucially, the researchers identified important methodological pitfalls — including age bias corrections and training data quality — that can distort results if ignored. This work advances the field toward a comprehensive, multi-omics biological aging framework.
Detailed Summary
Biological age clocks have become one of the most exciting tools in longevity research, offering a way to measure how fast your body is actually aging — not just how many birthdays you've had. But most existing clocks focus on a single data type or organ, missing the systemic nature of aging. This study pushes the field forward by integrating multiple biological layers across multiple organ systems.
Researcher Junhao Wen at Columbia University developed 11 proteome-based biological age gaps (ProtBAGs) using 2,448 plasma proteins drawn from 43,498 participants in the UK Biobank. Each ProtBAG was designed to capture aging dynamics in a specific organ system, providing a molecular-level complement to clinical and neuroimaging clocks developed previously.
Key findings show that combining these 11 protein-based clocks with nine previously established phenotype-based clocks — spanning organs including the brain, heart, lungs, kidneys, and liver — significantly improved predictions of systemic disease categories and all-cause mortality. Genetic analyses also revealed meaningful overlaps between ProtBAGs and disease endpoints, and Mendelian randomization-style approaches identified causal associations worthy of further clinical investigation.
Importantly, the study does not just report results — it also provides a rigorous methodological guide. The author highlights critical issues that can undermine clock development: age bias in training data, protein organ-specificity assumptions, sample size requirements, and the presence of underlying pathologies in training cohorts that can reduce generalizability.
The clinical implications are significant. A future clinical tool that integrates proteomics, imaging, and phenotypic data across organs could provide a far more personalized and accurate picture of a patient's biological aging trajectory. However, validation across diverse populations and longitudinal settings remains essential before clinical adoption. Summary is based on the abstract only.
Key Findings
- 11 organ-specific proteome-based biological age clocks were built from 2,448 plasma proteins in 43,498 participants.
- Combining protein and phenotype-based clocks across organs improved systemic disease and all-cause mortality predictions.
- Genetic overlap and causal associations were identified between multi-organ age gaps and disease endpoints.
- Age bias correction and training data quality are critical methodological factors that affect clock accuracy.
- A multi-organ, multi-omics framework outperforms single-organ or single-data-type aging clocks.
Methodology
Cross-sectional analysis of 43,498 UK Biobank participants using 2,448 plasma proteins to develop 11 organ-specific proteome-based biological age gaps. These were integrated with nine previously developed phenotype-based biological age gaps. Genetic overlap and causal disease associations were also investigated.
Study Limitations
Summary is based on the abstract only, so full methodological details and results tables are unavailable. The study relies on UK Biobank data, which may limit generalizability to non-European populations. Cross-sectional design limits causal inference despite Mendelian randomization approaches.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.